These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 32513782)
41. Berberine attenuates pulmonary arterial hypertension via protein phosphatase 2A signaling pathway both in vivo and in vitro. Luo J; Gu Y; Liu P; Jiang X; Yu W; Ye P; Chao Y; Yang H; Zhu L; Zhou L; Chen S J Cell Physiol; 2018 Dec; 233(12):9750-9762. PubMed ID: 30078229 [TBL] [Abstract][Full Text] [Related]
42. MicroRNA‑15a‑5p induces pulmonary artery smooth muscle cell apoptosis in a pulmonary arterial hypertension model via the VEGF/p38/MMP‑2 signaling pathway. Zhang W; Li Y; Xi X; Zhu G; Wang S; Liu Y; Song M Int J Mol Med; 2020 Feb; 45(2):461-474. PubMed ID: 31894295 [TBL] [Abstract][Full Text] [Related]
43. CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension. Zhuang W; Lian G; Huang B; Du A; Gong J; Xiao G; Xu C; Wang H; Xie L Mol Cell Biochem; 2019 May; 455(1-2):169-183. PubMed ID: 30511343 [TBL] [Abstract][Full Text] [Related]
50. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling. Cheng G; Wang X; Li Y; He L Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784 [TBL] [Abstract][Full Text] [Related]
51. alpha1A-adrenoceptor is involved in norepinephrine-induced proliferation of pulmonary artery smooth muscle cells via CaMKII signaling. Luo Q; Wang X; Liu R; Qiao H; Wang P; Jiang C; Zhang Q; Cao Y; Yu H; Qu L J Cell Biochem; 2019 Jun; 120(6):9345-9355. PubMed ID: 30520144 [TBL] [Abstract][Full Text] [Related]
52. The mechanism of the imbalance between proliferation and ferroptosis in pulmonary artery smooth muscle cells based on the activation of SLC7A11. Hu P; Xu Y; Jiang Y; Huang J; Liu Y; Wang D; Tao T; Sun Z; Liu Y Eur J Pharmacol; 2022 Aug; 928():175093. PubMed ID: 35700835 [TBL] [Abstract][Full Text] [Related]
53. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1. Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422 [TBL] [Abstract][Full Text] [Related]
54. CircATP2B4 promotes hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells via the miR-223/ATR axis. Guo J; Zhang L; Lian L; Hao M; Chen S; Hong Y Life Sci; 2020 Dec; 262():118420. PubMed ID: 32926932 [TBL] [Abstract][Full Text] [Related]
55. Topotecan prevents hypoxia-induced pulmonary arterial hypertension and inhibits hypoxia-inducible factor-1α and TRPC channels. Jiang Y; Zhou Y; Peng G; Liu N; Tian H; Pan D; Liu L; Yang X; Li C; Li W; Chen L; Ran P; Dai A Int J Biochem Cell Biol; 2018 Nov; 104():161-170. PubMed ID: 30266526 [TBL] [Abstract][Full Text] [Related]
56. Functional interaction between PDGFβ and GluN2B-containing NMDA receptors in smooth muscle cell proliferation and migration in pulmonary arterial hypertension. Quatredeniers M; Nakhleh MK; Dumas SJ; Courboulin A; Vinhas MC; Antigny F; Phan C; Guignabert C; Bendifallah I; Vocelle M; Fadel E; Dorfmüller P; Humbert M; Cohen-Kaminsky S Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L445-L455. PubMed ID: 30543306 [TBL] [Abstract][Full Text] [Related]
57. Transforming growth factor-beta1 upregulation triggers pulmonary artery smooth muscle cell proliferation and apoptosis imbalance in rats with hypoxic pulmonary hypertension via the PTEN/AKT pathways. Liu Y; Cao Y; Sun S; Zhu J; Gao S; Pang J; Zhu D; Sun Z Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):141-154. PubMed ID: 27297622 [TBL] [Abstract][Full Text] [Related]
58. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension. Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128 [TBL] [Abstract][Full Text] [Related]
59. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension. Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146 [TBL] [Abstract][Full Text] [Related]
60. Osteoprotegerin Disruption Attenuates HySu-Induced Pulmonary Hypertension Through Integrin αvβ3/FAK/AKT Pathway Suppression. Jia D; Zhu Q; Liu H; Zuo C; He Y; Chen G; Lu A Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28077433 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]